Royal Bank of Canada
ALLO icon

Royal Bank of Canada’s Allogene Therapeutics ALLO Stock Holding History

Royal Bank of Canada’s Portfolio ALLO Stock Details ALLO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$138K Buy
56,532
+7,738
+16% +$15.5K ﹤0.01% 4941
2025
Q4 		$67K Sell
48,794
-1,049,775
-96% -$1.38M ﹤0.01% 5395
2025
Q3 		$1.36M Buy
1,098,569
+112,269
+11% +$134K ﹤0.01% 3727
2025
Q2 		$1.11M Buy
986,300
+932,439
+1,731% +$1.24M ﹤0.01% 3808
2025
Q1 		$79K Buy
53,861
+20,101
+60% +$37.9K ﹤0.01% 5343
2024
Q4 		$72K Buy
33,760
+1,669
+5% +$4.12K ﹤0.01% 5502
2024
Q3 		$90K Buy
32,091
+3,077
+11% +$8.2K ﹤0.01% 5412
2024
Q2 		$67K Sell
29,014
-15,707
-35% -$46.3K ﹤0.01% 5509
2024
Q1 		$200K Sell
44,721
-18,088
-29% -$75.5K ﹤0.01% 4688
2023
Q4 		$202K Buy
62,809
+6,362
+11% +$18K ﹤0.01% 5092
2023
Q3 		$179K Buy
56,447
+7,473
+15% +$32.7K ﹤0.01% 4909
2023
Q2 		$244K Buy
48,974
+4,104
+9% +$22.2K ﹤0.01% 4558
2023
Q1 		$221K Buy
44,870
+2,962
+7% +$19K ﹤0.01% 4532
2022
Q4 		$264K Sell
41,908
-1,396
-3% -$12.9K ﹤0.01% 4636
2022
Q3 		$468K Sell
43,304
-186
-0.4% -$2.53K ﹤0.01% 4086
2022
Q2 		$495K Sell
43,490
-3,429
-7% -$30.4K ﹤0.01% 4106
2022
Q1 		$427K Sell
46,919
-18,066
-28% -$188K ﹤0.01% 4399
2021
Q4 		$970K Sell
64,985
-29,052
-31% -$513K ﹤0.01% 3836
2021
Q3 		$2.42M Buy
94,037
+971
+1% +$23.1K ﹤0.01% 2918
2021
Q2 		$2.43M Buy
93,066
+2,275
+3% +$64.9K ﹤0.01% 2894
2021
Q1 		$3.21M Buy
90,791
+47,756
+111% +$1.61M ﹤0.01% 2601
2020
Q4 		$1.09M Buy
43,035
+1,814
+4% +$59.1K ﹤0.01% 3420
2020
Q3 		$1.55M Sell
41,221
-12,971
-24% -$489K ﹤0.01% 2908
2020
Q2 		$2.32M Buy
54,192
+15,895
+42% +$575K ﹤0.01% 2497
2020
Q1 		$744K Buy
38,297
+1,349
+4% +$32.1K ﹤0.01% 3273
2019
Q4 		$960K Buy
36,948
+6,731
+22% +$185K ﹤0.01% 3477
2019
Q3 		$824K Buy
30,217
+7,241
+32% +$206K ﹤0.01% 3502
2019
Q2 		$617K Buy
22,976
+5,591
+32% +$156K ﹤0.01% 3707
2019
Q1 		$503K Sell
17,385
-407
-2% -$11.8K ﹤0.01% 3722
2018
Q4 		$479K Buy
+17,792
New +$473K ﹤0.01% 3730

Other funds holding ALLO

P
Pfizer New York $239M AUM 232.47% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
TGA
TPG GP A Fort Worth, Texas $3.68B AUM 14.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Royal Bank of Canada's ALLO Position: Q1 2026 in Review

Royal Bank of Canada increased its Allogene Therapeutics (ALLO) stake by 16% in Q1 2026, buying an estimated $15.5K and bringing the position to 56,532 shares worth $138K. The position accounts for ﹤0.01% of the portfolio, ranked #4941.

Royal Bank of Canada first reported a position in ALLO in Q4 2018 and has held it in 30 quarters since. The position peaked at $3.21M in Q1 2021. 208 funds tracked by Wall St. Rank hold ALLO as of Q1 2026.

  • Royal Bank of Canada held 56,532 shares of Allogene Therapeutics worth $138K as of Q1 2026.
  • Royal Bank of Canada bought 7,738 Allogene Therapeutics shares in Q1 2026, an estimated $15.5K.
  • Allogene Therapeutics made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #4941 holding.
  • Royal Bank of Canada first reported a position in Allogene Therapeutics in Q4 2018 and has held it in 30 quarters since.
  • Royal Bank of Canada's Allogene Therapeutics position peaked at $3.21M in Q1 2021.
  • 208 funds tracked by Wall St. Rank held Allogene Therapeutics as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.